Stock Updates

Today’s Top Gainers in the Market IDEXX Laboratories, Inc. (NASDAQ:IDXX) from Healthcare

Today’s top gainers include the company IDEXX Laboratories, Inc. (NASDAQ:IDXX) which is in the industry Diagnostic Substances, gaining 0.91% today. In the last week its performance is 3.22%, and 23.37% for the past quarter. Currently, IDEXX Laboratories, Inc., IDXX has a target price of 115.5, so today’s gain of 0.91% is a significant step towards its target price. The GAP today is therefore 0.73%.

IDEXX Laboratories, Inc. (NASDAQ:IDXX), has a market cap of 10128.34, and is based in USA. Insider ownership is at 1.30%, and institutional ownership is 95.10%.

At the current price of 113.09, it has a dividend yield of *TBA, and its target price is 115.5. This is with a profit margin of 11.90%, and total debt/equity of *TBA. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has a P/E of 51.2, as well as a forward P/E of 42.13.

With a current EPS of 2.21, and a forecasted EPS growth for next year at 13.68%,IDEXX Laboratories, Inc. (NASDAQ:IDXX) has had a EPS growth for the past five years at 11.60%. For the next five years EPS growth is projected to be 13.67%.

Performance for the year is 47.54%. Since its IPO date on 6/24/1991, the total performance to date is 55.09%.

Volume today for IDEXX Laboratories, Inc. (NASDAQ:IDXX), is 442200, while its average volume is 516.93. Whilst the total gain today was 0.91%, it did have a day high of -1.71%.

Volatility for this week has been at 1.55%, and 1.56% for the month. The 52-week low for IDEXX Laboratories, Inc., IDXX has been 78.15%, while the 52-week-high has reached -1.71%.

Looking at its return of investments, which is 22.10%, and its return on assets is 13.60%. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has an operating margin of 18.70%. With a sales growth of 12.90% quarter over quarter. Bearing in mind that IDEXX Laboratories, Inc., IDXX is in the sector Healthcare, its long-term debt/equity is *TBA, and has a current ratio of 1 and 0.8 for quick ratio.

So what is the value of IDEXX Laboratories, Inc.? Well its PEG is 3.75, and the P/S is 5.99, along with a P/B of *TBA. Meanwhile it has a p/cash of 27.36.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment